XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCKHOLDERS’ DEFICIT AND STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Fair Value Assumptions

The following assumptions were used in the fair value method calculations:

STOCKHOLDERS' EQUITY (DEFICIT) & STOCK-BASED COMPENSATION
   Three Months Ended
December 31,
   Nine Months Ended
December 31,
 
   2021   2020   2021   2020 
Risk-free interest rates   1.26% - 1.36%    0.38%    0.8% - 1.36%    0.28% - 0.38% 
Volatility   197% - 253%    87%    89% - 370%    87% - 127% 
Expected life (years)   5.06.0    5.25.7    5.0 - 6.2    5.0 - 6.0 
Dividend yield                
Schedule of Stock Option activity

A summary of stock option activity under the Plan is presented below:

STOCKHOLDERS' EQUITY (DEFICIT) & STOCK-BASED COMPENSATION (Details 2)
       Options Outstanding 
   Shares
Available
for Grant
   Number of
Shares
   Weighted
Average
Exercise
Prices
 
Balance at March 31, 2021   136,082    1,197,252   $5.25 
Options granted   (60,774)   60,774    12.69 
Share awards   (1,836)        
Options cancelled and returned to the Plan   7,547    (7,547)   8.61 
Balance at June 30, 2021   81,089    1,250,479    5.58 
Additional shares authorized under the Plan   1,333,334         
Options granted   (396,384)   396,384    12.15 
Share awards   (3,636)        
Options cancelled and returned to the Plan   49,213    (49,213)   7.02 
Balance at September 30, 2021   1,063,546    1,597,650    7.17 
Options granted   (266,112)   259,559    9.99 
Share awards   (5,775)         
Options cancelled and returned to the Plan   29,073    (11,256)   7.24 
Balance at December 31, 2021   820,732    1,845,953    7.57 
Schedule of Outstanding and Exercisable Option, Range

The following table summarizes the range of outstanding and exercisable options as of December 31, 2021:

STOCKHOLDERS' EQUITY (DEFICIT) & STOCK-BASED COMPENSATION (Details 3)
   Options Outstanding   Options Exercisable 
Range of Exercise Price  Number
Outstanding
   Weighted
Average
Remaining
Contractual
Life
(in Years)
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Aggregate
Intrinsic
value
 
$1.98 - $17.70   1,845,953    8.13   $7.57    1,011,586   $5.10   $3,564,268